CORC

在结果中检索

CORC

浏览/检索结果: 共163条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Conformation of the Macrocyclic Drug Lorlatinib in Polar and Nonpolar Environments: A MD Simulation and NMR Study 期刊论文
ACS OMEGA, 2019, 卷号: 4, 期号: 26, 页码: 22245-22250
作者:  Peng, Cheng;  Atilaw, Yoseph;  Wang, Jinan;  Xu, Zhijian;  Poongavanam, Vasanthanathan
收藏  |  浏览/下载：23/0  |  提交时间：2020/07/01
'Personalized Medicines-Molecular Signature - based Drug Discovery and Development', Strategic Priority Research Program of the Chinese Academy of Sciences[XDA12020108] 项目
项目编号: XDA12020108, 资助机构: 'Personalized Medicines-Molecular Signature - based Drug Discovery and Development', Strategic Priority Research Program of the Chinese Academy of Sciences, 2019-
-
收藏  |  浏览/下载：14/0  |  提交时间：2020/07/01
Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5 alpha-Reductase 期刊论文
SCIENTIFIC REPORTS, 2019, 卷号: 9, 页码: 10
作者:  Liu, Jiakuan;  Fang, Tian;  Li, Meiqian;  Song, Yuting;  Li, Junzun
收藏  |  浏览/下载：34/0  |  提交时间：2020/07/01
Common activation mechanism of class A GPCRs 期刊论文
ELIFE, 2019, 卷号: 8, 页码: 31
作者:  Zhou, Qingtong;  Yang, Dehua;  Wu, Meng;  Guo, Yu;  Guo, Wangjing
收藏  |  浏览/下载：66/0  |  提交时间：2020/07/01
Personalized Medicines Molecular Signature-based Drug Discovery and Development of the Strategic Priority Research Program of the Chinese Academy of Sciences[XDA12020320] 项目
项目编号: XDA12020320, 资助机构: Personalized Medicines Molecular Signature-based Drug Discovery and Development of the Strategic Priority Research Program of the Chinese Academy of Sciences, 2019-
-
收藏  |  浏览/下载：20/0  |  提交时间：2020/07/01
Imaging Tumorous Methylglyoxal by an Activatable Near-Infrared Fluorescent Probe for Monitoring Glyoxalase 1 Activity 期刊论文
ANALYTICAL CHEMISTRY, 2019, 卷号: 91, 期号: 24, 页码: 15577-15584
作者:  Ding, Chunyong;  Wang, Fengyang;  Dang, Yijing;  Xu, Zhiai;  Li, Lingling
收藏  |  浏览/下载：18/0  |  提交时间：2020/07/01
Personalized Medicines-Molecular Signature-based Drug Discovery and Development, Strategic Priority Research Program of the Chinese Academy of Sciences[XDA12020113] 项目
项目编号: XDA12020113, 资助机构: Personalized Medicines-Molecular Signature-based Drug Discovery and Development, Strategic Priority Research Program of the Chinese Academy of Sciences, 2019-
-
收藏  |  浏览/下载：3/0  |  提交时间：2020/07/01
DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models 期刊论文
ARTHRITIS RESEARCH & THERAPY, 2019, 卷号: 21, 期号: 1, 页码: 15
作者:  Zhang, Zongwang;  Wu, Yanwei;  Wu, Bing;  Qi, Qing;  Li, Heng
收藏  |  浏览/下载：29/0  |  提交时间：2020/07/01
'Personalized Medicines-Molecular Signature-based Drug Discovery and Development', Strategic Priority Research Programme of the Chinese Academy of Sciences[XDA12050201] 项目
项目编号: XDA12050201, 资助机构: 'Personalized Medicines-Molecular Signature-based Drug Discovery and Development', Strategic Priority Research Programme of the Chinese Academy of Sciences, 2019-
-
收藏  |  浏览/下载：5/0  |  提交时间：2020/07/01
KinomeX: a web application for predicting kinome-wide polypharmacology effect of small molecules 期刊论文
BIOINFORMATICS, 2019, 卷号: 35, 期号: 24, 页码: 5354-5356
作者:  Li, Zhaojun;  Li, Xutong;  Liu, Xiaohong;  Fu, Zunyun;  Xiong, Zhaoping
收藏  |  浏览/下载：79/0  |  提交时间：2020/07/01

©版权所有 ©2017 CSpace - Powered by CSpace